Cardiovascular disease and risk in COPD: a state of the art review
Article in Expert Review of Cardiovascular Therapy (March 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
High use of short-acting β2-agonists in COPD is associated with an increased risk of exacerbations and mortality
Article in ERJ Open Research (May 2023)
Towards precision in defining COPD exacerbations
Article in Breathe (September 2021)